Axiom-4 to carry 1st FDA-approved cancer drug for space testing

Microgravity provides unique advantages for cancer research, with tumours growing approximately twice as fast in space. Dr Jamieson noted a doubling in growth of mini-tumours within just 10 days, effectively mimicking aggressive cancer progression in patients and enabling researchers to obtain more reliable scientific results in shorter time frames.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/0JBqilG
via